INTERNATIONAL PATENT: NARENDRAN, ARUMUGAVADIVEL FILES APPLICATION FOR "IDENTIFICATION, DESIGN AND VALIDATION OF PUBLIC NEOANTIGENS FOR THE TREATMENT OF DOWN SYNDROME-ASSOCIATED LEUKEMIA"

GENEVA, Nov. 23 -- NARENDRAN, Arumugavadivel (31 Country Lane TerraceCalgary, Alberta T3Z 1H8) filed a patent application (PCT/CA2025/050701) for "IDENTIFICATION, DESIGN AND VALIDATION OF PUBLIC NEOANTIGENS FOR THE TREATMENT OF DOWN SYNDROME-ASSOCIATED LEUKEMIA" on May 14, 2025. With publication no. WO/2025/236094, the details related to the patent application was published on Nov 20, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): TRAN, Son (107 Applewood Way SECalgary, Alberta T2A 7N1)

Abstract: Identification, Design and Validation of Public Neoantigens and Tumor-associated Antigen vacci...